AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Schnog, JB Duits, AJ
Citation: Jb. Schnog et Aj. Duits, Untitled - Reply, CLIN IMMUNO, 98(3), 2001, pp. 384-384

Authors: Schnog, JB Kater, AP Mac Gillavry, MR Duits, AJ Lard, LR van der Dijs, FPL Brandjes, DPM ten Cate, H van Eps, LWS Rojer, RA
Citation: Jb. Schnog et al., Low adjusted-dose acenocoumarol therapy in sickle cell disease: A pilot study, AM J HEMAT, 68(3), 2001, pp. 179-183

Authors: Schnog, JB Keli, SO Pieters, RA Rojer, RA Duits, AJ
Citation: Jb. Schnog et al., Duffy phenotype does not influence the clinical severity of sickle cell disease, CLIN IMMUNO, 96(3), 2000, pp. 264-268

Authors: Schnog, JB van der Dijs, FPL Brouwer, DAJ Duits, AJ Muskiet, FD Muskiet, FAJ
Citation: Jb. Schnog et al., Plasma homocysteine levels in sickle cell disease and the need for folate supplementation, J PED H ONC, 22(2), 2000, pp. 184-185

Authors: Gallione, CJ Scheessele, EA Reinhardt, D Duits, AJ Berg, JN Westermann, CJJ Marchuk, DA
Citation: Cj. Gallione et al., Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: evidence for a founder effect, HUM GENET, 107(1), 2000, pp. 40-44

Authors: Reuvekamp, A Velsing-Aarts, FV Poulina, IEJ Capello, JJ Duits, AJ
Citation: A. Reuvekamp et al., Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia, BR J OBST G, 106(10), 1999, pp. 1019-1022

Authors: Lard, LR Mul, FPJ de Haas, M Roos, D Duits, AJ
Citation: Lr. Lard et al., Neutrophil activation in sickle cell disease, J LEUK BIOL, 66(3), 1999, pp. 411-415

Authors: Saleh, AW Hillen, HFP Duits, AJ
Citation: Aw. Saleh et al., Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy, ACT HAEMAT, 102(1), 1999, pp. 31-37

Authors: Duits, AJ Schnog, JB Lard, LR Saleh, AW Rojer, RA
Citation: Aj. Duits et al., Elevated IL-8 levels during sickle cell crisis, EUR J HAEMA, 61(5), 1998, pp. 302-305
Risultati: 1-9 |